R & d systems INC:1107462 [16-002479] recombinant human/mouse/RAT activin a protein
Ended Awarded
- Contract number
- HHSN28100001
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $6,974
Award facts
- Contract value 100% obligated
- $6,974.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6810 Chemicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a $6,974.05 firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Heart, Lung, and Blood Institute (NHLBI) on March 11, 2016. The contract, which utilized no set-aside designation and operated under open competition, was for the supply of recombinant human/mouse/rat Activin A protein, a bioactive reagent commonly used in cardiovascular and pulmonary research applications. The award was completed by August 31, 2016, with performance undertaken at the company's Minneapolis, Minnesota facility.
This task order represents a typical call against R&D Systems' comprehensive $10 million single-award BPA with the Office of Logistics and Acquisition Operations, which remains active through September 30, 2025. The BPA enables flexible procurement of biological materials, laboratory supplies, and specialized research reagents across multiple National Institutes of Health institutes. As a leading provider of recombinant proteins and research reagents to the federal government, R&D Systems has consistently delivered critical scientific materials supporting biomedical research initiatives, including studies in infectious disease, cancer biology, and translational science across various NIH-funded programs.
Quick answers
Who was awarded contract HHSN28100001?
HHSN28100001 was awarded to Research And Diagnostic Systems, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on March 11, 2016.
How much is contract HHSN28100001 worth?
The government has obligated $6,974 on HHSN28100001.
Is contract HHSN28100001 an order under another contract?
Yes. HHSN28100001 is a BPA call under HHSN263201600021B, a blanket purchase agreement.
Was contract HHSN28100001 competed?
The extent of competition for HHSN28100001 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award